NDT Advance Access originally published online on October 4, 2005
Nephrology Dialysis Transplantation 2005 20(12):2587-2593; doi:10.1093/ndt/gfi159
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Editorial Comment
ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends
Fresenius Medical Care, Bad Homburg, Germany
Correspondence and offprint requests to: Aileen Grassmann, Fresenius Medical Care, Daimlerstrasse 15, 61352 Bad Homburg, Germany. Email: Aileen.Grassmann@fmc-ag.com
Keywords: demography; dialysis transplantation; ESRD; global; prevalence; transplantation
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
Since the beginning of maintenance therapy for end-stage renal disease (ESRD) through dialysis or transplantation, the number of patients treated for terminal kidney failure worldwide has continued to grow at a rate that is far in excess of the growth rate of the general population. By 2001, more than 1 million patients were reported worldwide to receive dialysis treatment alone, with the numbers growing at an annual global average rate of 7% [1,2]. The main factors contributing to the continued growth are the universal ageing of populations, multi-morbidity, higher life-expectancy of treated ESRD patients and increasing access of a generally younger patient population to treatment in countries in which access had previously been limited [3–6]. Solutions targeting the prevention or reversal of renal disease receive widespread attention, but have as yet failed to significantly change the development of global patient numbers. A superior and
|
Methods |
|---|
|
Results |
|---|
Treated ESRD, dialysis and transplant patients
Haemodialysis and peritoneal dialysis patients and selected treatment-related factors
|
Discussion |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. J. Caskey, V. S. Stel, R. F. Elliott, K. J. Jager, A. Covic, A. Cusumano, C. Geue, A. Kramer, B. Stengel, and A. M. MacLeod The EVEREST study: an international collaboration NDT Plus, October 19, 2009; (2009) sfp146v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Postma and D. de Zeeuw The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus Nephrol. Dial. Transplant., October 1, 2009; 24(10): 2975 - 2983. [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Moraes, R. Pecoits-Filho, S. C. Ribeiro, M. Rigo, M. M. Silva, P. S. Teixeira, D. D. Pasqual, R. Fuerbringer, and M. C. Riella PERITONEAL DIALYSIS IN BRAZIL: TWENTY-FIVE YEARS OF EXPERIENCE IN A SINGLE CENTER Perit. Dial. Int., September 1, 2009; 29(5): 492 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Sica Hyperkalemia Risk in Chronic Kidney Disease: Deterrent to the Use of Aldosterone Receptor Antagonism or Not Hypertension, May 1, 2009; 53(5): 749 - 750. [Full Text] [PDF]
|
|
|
|
|
|
N. Bouvier, P.-Y. Durand, A. Testa, C. Albert, V. Planquois, J.-P. Ryckelynck, and T. Lobbedez Regional discrepancies in peritoneal dialysis utilization in France: the role of the nephrologist's opinion about peritoneal dialysis Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1293 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Navaneethan, S. U. Nigwekar, A. R. Sehgal, and G. F.M. Strippoli Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 542 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Power, N Duncan, and C Goodlad Advances and innovations in dialysis in the 21st century Postgrad. Med. J., February 1, 2009; 85(1000): 102 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tangri, D. Ansell, and D. Naimark Predicting technique survival in peritoneal dialysis patients: comparing artificial neural networks and logistic regression Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2972 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella Reimbursement and economic factors influencing dialysis modality choice around the world Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mahdavi-Mazdeh, M. Zamyadi, and M. Nafar Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran Nephrol. Dial. Transplant., January 1, 2008; 23(1): 288 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data? Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Han, S. C. Lee, S. V. Ahn, J. E. Lee, D. K. Kim, T. H. Lee, S. J. Moon, B. S. Kim, S.-W. Kang, K. H. Choi, et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2653 - 2658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawaguchi VARIOUS OBSTACLES TO PERITONEAL DIALYSIS DEVELOPMENT IN JAPAN: TOO MUCH MONEY? TOO MUCH FEAR? Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S56 - S58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hidai Inequality of renal replacement therapy in the low-income countries Nephrol. Dial. Transplant., February 1, 2007; 22(2): 663 - 665. [Full Text] [PDF]
|
|
|
|
|
|
A. J. Ghods and S. Savaj Iranian Model of Paid and Regulated Living-Unrelated Kidney Donation Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1136 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jacobs Costs and benefits of improving renal failure treatment--where do we go? Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2049 - 2052. [Full Text] [PDF]
|
|
|
|
|
|
M. S. MacGregor, J. W. M. Agar, and C. R. Blagg Home haemodialysis--international trends and variation Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1934 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khanna Peritoneal Inflammation and High Transport Status Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 167 - 169. [Full Text] [PDF]
|
|